Exact Sciences

Jun 07, 2018

Exact Sciences Launches $190M Senior Notes Offering

The company said it plans to use the net proceeds for general corporate purposes, including for working capital and possible acquisitions.

May 30, 2018

Exact Sciences Shares Rise Sharply on New Colorectal Cancer Screening Recommendation

The American Cancer Society today lowered the recommended age for screening patients at average risk for the disease to 45 from 50 years old.

May 01, 2018

Stock Prices of Dx Firms Rebound in April; 360Dx Index Outperforms Broader Market

The share prices of 20 companies in the 360Dx Index rose last month, with Exact Sciences, Natera, Invitae, and NeoGenomics the biggest gainers.

Apr 26, 2018

Exact Sciences Q1 Revenues Up 87 Percent

The company said test volume rose 87 percent to 186,000 during the quarter.

Feb 22, 2018

Exact Sciences Q4 Revenues Up 148 Percent

The company said 571,000 people were screened for colon cancer with its noninvasive Cologuard test in 2017.

Jan 19, 2018

Exact Sciences Adds New Protein Markers to Portfolio With Armune Acquisition

Premium

Armune, a University of Michigan spinout, owns licensing rights to protein biomarkers from the university for lung, breast, and prostate cancer.

Jan 18, 2018

Exact Sciences Nets $671M in Senior Notes Offering

Underwriter Merrill Lynch exercised in full the option to purchase up to an additional $90M in senior notes on top of a $600M notes offering announced last week.

Jan 17, 2018

Exact Sciences Shares Drop on Potential Competitive Threat From Liquid Biopsy

Investors in Exact Sciences went on a selling spree after CellMax publicized data suggesting its test could outperform Cologuard for the early detection of colorectal cancer.

Jan 11, 2018

Exact Sciences Plans $600M Senior Notes Offering

The company said it will use the proceeds from the offering for general corporate and working capital purposes.

Jan 10, 2018

JPM Healthcare Day 2: LabCorp, DiaSorin, Danaher, Exact Sciences, Hologic, and More

Among the diagnostic firms presenting at the conference on Tuesday were lab giant LabCorp, diversified medical products firm Hologic, and MDx startups, such as Adaptive Biotechnologies.

Pages